首页 正文

Molecular characterisation of KRAS mutations in non-small cell lung cancer across all stages

{{output}}
Introduction: Kirsten rat sarcoma virus (KRAS) mutations (KRASms) are detected in approximately 25% of non-small cell lung cancer (NSCLC) patients with adenocarcinoma. Next-generation sequencing (NGS) has enabled the identificati... ...